Medical Device News Magazine

Choose Health Makes More At-Home Blood Tests Available for Private Label Use

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Choose Health is excited to expand its popular private label product line to include additional at-home blood tests. A wide variety of healthcare providers from weightloss clinics to med spas to pharmacies will be able to leverage data analysis technology in addition to having the opportunity to sell white label at-home blood tests.

Healthcare providers can now offer private label at-home tests for:

  • Metabolic function
  • Liver function
  • Kidney function
  • Thyroid function
  • Male hormones
  • Female hormones
  • Adrenal function
  • Stress levels

These at-home blood tests cover 29+ biomarkers:

  • Total Cholesterol
  • HDL Cholesterol
  • LDL Cholesterol
  • Triglycerides
  • Average Blood Sugar (hbA1c)
  • Natriuretic Peptide (NT-ProBNP)
  • Visceral Fat (Waist : Height Ratio)
  • Oxidative Stress (GGT)
  • Inflammation (hs-CRP)
  • Vitamin D (25-OH vitamin D)
  • Total Testosterone
  • Free Testosterone
  • Estradiol
  • Luteinizing Hormone (LH)
  • Follicle-Stimulating Hormone (FSH)
  • Progesterone
  • Prostate-Specific Antigen (PSA)
  • Thyroid (TSH)
  • Sex Hormone Binding Globulin (SHBG)
  • Anti-Mullerian Hormone (AMH)
  • Dehydroepiandrosterone Sulfate (DHEA-S)
  • Cortisol
  • Prolactin
  • Estimated Glomerular Filtration Rate (EGFR)
  • Creatinine
  • Aspartate Aminotransferase (AST)
  • Alanine Transaminase (ALT)
  • Total Bilirubin
  • Alkaline Phosphatase

Private label at-home blood tests aren’t limited to private practitioners. They can be resold online or in-store at a variety of locations. Choose Health’s white label partners can create customized test panels that utilize dried blood spot (DBS) testing technology. The tests are affordable, stable and easy for anyone to administer. The white-label service is all-inclusive. Everything that’s needed for at-home blood testing is included:

  • Finger-prick test supplies
  • Inbound shipping
  • Outbound shipping
  • Physicians requisition processing
  • 24/7 customer service

Finger prick testing provides powerful information with just a few drops of blood. But often people are deterred from venipunctures, blood draw clinics and the time & cost incurred. Therefore, our mission is to provide easier and more affordable access to functional medicine.” Matthew McDermott, Msc, Head of Research & Development at Choose Health.

Private label at-home blood tests also include Choose Health’s HIPAA-compliant tracking platform. The platform features a customized dashboard so that customers can review the results and get recommendations. Customers receive a personalized video going over each biomarker and how to improve them.

The results dashboard also gives healthcare providers another platform for:

  • Gathering customer data to enhance services.
  • Communicating with customers.
  • Creating highly targeted marketing campaigns.
  • Branding and finding brand evangelists.
  • Repeat sales through tracking multiple test results.
  • Improving customer experience and product value.

The goal for Choose Health is to create a seamless, multi-channel branded experience no matter what type of at-home blood test is being taken. The customer taking the test will only be exposed to private label branding that’s added to:

  • Product packaging
  • Product inserts
  • Instructions
  • Results platform interface
  • Online customer intake form
  • Emails

Choose Health has gone one step further by ensuring all redirect links also connect to the retailer’s website.

At-home health testing will be a $2 billion industry within a few years. Choose Health is poised to be the reliable test provider of choice that is able to supply a selection of white label at-home tests that are paired with a results platform for exceptional value and customer experience.

If you are interested in hearing more about Choose Health’s white-label solutions, feel free to book a call with an expert today – Book here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”